Expected impact
The action funded under this call for proposals should contribute to increased international cooperation among researchers and funders, catalyse research synergies, and leverage resources and investments in order to achieve rapid advances in the development of new or improved anti-malarial drugs or drug combinations. The action should have the potential to achieve maximum impact in the field and to make a significant contribution to the objectives of the EDCTP3 programme, and in particular:
- Contribute towards combatting drug resistance through development of new or improved antimalarial products;
- Lead to the advancement of new drugs and/or drug combinations, with the aim of registration of new drug(s) and/or drug combinations for treatment and prevention of malaria in SSA and globally;
- Contribute to the reduction of malaria mortality and morbidity in SSA, particularly in pregnant women, infants and children and thus contribute to achieving SDG 3 'Ensure healthy lives and promote well-being for all at all ages'.
Proposals are expected to include the effective in-kind and/or financial contribution of contributing partners, in order to produce meaningful and significant effects enhancing the impact of the related research activities.
Applicant consortium
The contributions from contributing partners should correspond to the amounts they have committed in the letter of endorsement
...
